These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2862449)

  • 1. Duodenitis and ulcer relapse.
    Lee FI
    Lancet; 1985 Aug; 2(8449):277. PubMed ID: 2862449
    [No Abstract]   [Full Text] [Related]  

  • 2. Duodenitis and ulcer relapse.
    Prichard PJ; Kerr GD
    Lancet; 1985 Jul; 2(8446):102. PubMed ID: 2861516
    [No Abstract]   [Full Text] [Related]  

  • 3. Histamine-2 receptor antagonists.
    Kumar P; Yachha SK; Misra S; Mehta S
    Indian Pediatr; 1992 Aug; 29(8):1019-23. PubMed ID: 1360945
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of histamine H2 receptor blockaders on the proteolytic activity in patients with ulcers].
    Bashir BM
    Lab Delo; 1990; (4):25-7. PubMed ID: 1695268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of raniberl in the combined treatment of peptic ulcer patients].
    Kharchenko NV; Rodonezhskaia EV; Zagoruĭko ZhV
    Lik Sprava; 1997; (5):127-30. PubMed ID: 9491719
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of relapse rate on the choice of duodenal ulcer therapy.
    Drug Ther Bull; 1987 Oct; 25(20):77-80. PubMed ID: 2890508
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of maintenance therapy by H2RA on the recurrence of gastric and duodenal ulcer and on the occurrence of reflux esophagitis, gastric erosions, and duodenal erosions after H. pylori eradication].
    Maeyama S; Yoshihara H; Kamada T; Kubota S; Kobayashi I; Tsuji S; Kawano S
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():512-5. PubMed ID: 16363591
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to "H2-receptor antagonists and duodenal ulcer recurrence".
    Kurata JH; Nogawa AN; Koch GG
    Am J Gastroenterol; 1988 Dec; 83(12):1427-9. PubMed ID: 2904219
    [No Abstract]   [Full Text] [Related]  

  • 9. Relapse of duodenal ulcer.
    Wormsley KG
    Br Med J (Clin Res Ed); 1986 Dec; 293(6560):1501-2. PubMed ID: 2879600
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of H2-receptor antagonists in the treatment of duodenitis.
    Laguzzi E; Blago MR; Girmania P; Sitar G
    Tokai J Exp Clin Med; 1992 Jul; 17(2):63-6. PubMed ID: 1359681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking, gastric secretion, and inhibition by H2 receptor antagonists.
    Deakin M; Ramage J; Gray SP; Billings J; Colin-Jones D; Williams JG
    Lancet; 1985 May; 1(8436):1049. PubMed ID: 2859502
    [No Abstract]   [Full Text] [Related]  

  • 12. H2-receptor antagonists in duodenal ulceration.
    Wormsley KG; Saunders JH
    Lancet; 1977 May; 1(8019):1000. PubMed ID: 67431
    [No Abstract]   [Full Text] [Related]  

  • 13. Women and duodenal ulcer.
    Bianchi Porro G; Prada A; Petrillo M; Lazzaroni M
    Br Med J (Clin Res Ed); 1981 Jul; 283(6285):235. PubMed ID: 6114771
    [No Abstract]   [Full Text] [Related]  

  • 14. Maintenance therapy of duodenal ulcer with H2-receptor antagonists: a re-appraisal of the meta-analysis of Palmer et al.
    Koch GG; Kurata JH; Nogaway AN
    Aliment Pharmacol Ther; 1991 Aug; 5(4):441-7. PubMed ID: 1685676
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
    Korman MG; Hansky J; Eaves ER; Schmidt GT
    Gastroenterology; 1983 Oct; 85(4):871-4. PubMed ID: 6136450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The H2-receptor antagonist era in duodenal ulcer disease.
    Marks IN
    Yale J Biol Med; 1992; 65(6):639-48;discussion 689-92. PubMed ID: 1364125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of peptic ulcer: a dilemma.
    Freedman S
    N Engl J Med; 1977 Dec; 297(23):1293. PubMed ID: 21350
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term effects and after-effects of treatment of duodenal ulcer with metiamide.
    Saunders JH; Wormsley KG
    Lancet; 1977 Apr; 1(8015):765-7. PubMed ID: 66567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the H2 receptor antagonists change the natural history of duodenal ulcer disease?
    Bardhan KD
    Am J Gastroenterol; 1994 Jan; 89(1):3-6. PubMed ID: 7903845
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.